FDA Drug recall D-0650-2022
Alprazolam C-IV 1 mg 60-count bottles, Rx Only, Dist
- FDA Drug
- Class II
- terminated
- Published 2022-03-16
On 2022-03-16 the FDA classified a Class II recall of Alprazolam C-IV 1 mg 60-count bottles, Rx Only, Dist by Direct Rx, citing CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Tab Laboratories Inc.).
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0650-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-03-04 |
| Published | 2022-03-16 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Direct Rx |
| Distribution | FL, GA, LA |
Product
Alprazolam C-IV 1 mg 60-count bottles, Rx Only, Dist. By: Par Pharmaceutical Chestnut Ridge, NY 10977 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 61919-836-60
Reason
CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Tab Laboratories Inc.)
Identifiers
| code_info | Lot #: 19AU1910 Exp. 5/31/22 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0650-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.